450. CEREBELLAR α6GABAA RECEPTOR AS A POTENTIAL THERAPEUTIC TARGET FOR RELIEVING CORE SYMPTOMS OF AUTISM: A PRECLINICAL STUDY IN PRENATAL VALPROIC ACID-EXPOSURE RATSPublished on 2025-08-184 months ago